N Awofeso
This paper discusses a model for optimising the screening of prison inmates, and vaccinating them against hepatitis B infection. Hepatitis B and other blood borne infections are common in prison populations worldwide because of previous or current intravenous drug use and unprotected sexual intercourse. Preliminary �?�?��?½ findings from the implementation of the model described in New SouthWales prison settings highlight its signi�?�?��?½ficant potential for enhancing clinical accountability, as well as improving systems for vaccinating prison inmates. It is however inadequate for optimising sero-conversion, or vaccination follow-up, rates.Such aspects require concurrent adoption of complementary models.
